2024
Anna Schwendeman, PhD, H.W. Vahlteich Professor of Pharmaceutical Sciences College of Pharmacy, University of Michigan
Synthetic High‐Density Lipoproteins – Nano Medicine and Drug Delivery Carriers
2023
Ann E. Weber, PhD, Senior Vice President, Research and Development, Kallyope Inc.
There and Back Again: Therapies for the Treatment of Obesity and Diabetes
2022
George Painter, PhD, Emory University, School of Medicine, CEO of DRIVE (Drug Innovation Ventures at Emory) and Executive Director of The Emory Institute for Drug Development
Developing a Drug in a Pandemic: the Evolution of Molnupiravir as a Treatment
2020
Timothy Heffron, PhD, Senior Director and Head of Oncology/Cancer Immunology Chemistry at Genentech
Considerations in the Discovery of Small Molecule Kinase Inhibitors for the Treatment of Brain Tumors and the Discovery of GDC-0084
2019
Kathleen Hillgren, PhD, Drug Disposition, Lilly Research Laboratories, Indianapolis, IN
Translation of In Vitro Transporter Data into the Clinic
2018
Peter Senter, Vice President of Chemistry at Seattle Genetics, Inc.
Antibody-based therapeutics for cancer therapy: An early stage research to a clinically approved drug
2017
Lisa Benincosa, PhD '93
Evolution of Translational PK/PD: A Pharma Perspective
2016
John Eng, MD
A Drug Discovery
2015
Hank Kung, PhD
Development of Imaging Agents for Diagnosing Alzheimer’s Disease
2014
A. Douglas Kinghorn, PhD
The Enduring Contribution of Natural Products to the Pharmaceutical Sciences
2013
Wolfgang Sadee, PhD
Optimizing Drug Therapy on Person at a Time: How will Pharmacogenomics Succeed
2012
Christopher Lipinski, PhD
Drug Discovery and Chemical Biology: Lessons Learned and Times of Change
